Get started
Author

Peter P. De Cruz

Observed names: P Cruz, P De Cruz, P P De Cruz, P de Cruz, P. Cruz, P. De Cruz, P. P. De Cruz, P.P. De Cruz, Peter Cruz, Peter De Cruz, Peter DeCruz, Peter De Cruz, Peter Dr Cruz, Peter P De Cruz, Peter de Cruz, Peter-Phillip De Cruz, de Cruz, P.
Observed institutions: The Royal Melbourne Hospital, The University of Melbourne, University of Staffordshire, Royal Australasian College of Physicians, Austin Hospital, St Vincent's Hospital Melbourne, St Vincent's Hospital Sydney, Eastern Health, St. Vincent's University Hospital, Sea Level Research (United Kingdom), Asian Pacific AIDS Intervention Team, Melbourne Health, Austin Health, Imperial College London, Keele University, Monash University, Liverpool John Moores University, Marvell (Israel)
ORCID: 0000-0002-3399-7236
Observed ORCID: 0000-0002-3399-7236
OpenAlex ID: A5017657989
Crohn's disease management after intestinal resection: a randomised trial
2014 · Peter De Cruz, Michael A Kamm, et al. · The Lancet · 619
Inflammatory bowel disease in Asia: A systematic review
2012 · Lani Prideaux, Michael A Kamm, et al. · Journal of Gastroenterology and Hepatology · 345
PDF
Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease
2014 · Benjamin Pariente, Jean-Yves Mary, et al. · Gastroenterology · 321
PDF
Systematic review: predicting and optimising response to anti‐ TNF therapy in Crohn's disease – algorithm for practical management
2015 · N. S. Ding, A. Hart, et al. · Alimentary Pharmacology & Therapeutics · 310
Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
2015 · Emily K. Wright, Michael A. Kamm, et al. · Gastroenterology · 280
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
2023 · Johan Burisch, Mirabella Zhao, et al. · ˜The œLancet. Gastroenterology & hepatology · 209
Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review
2011 · Lani Prideaux, Peter De Cruz, et al. · Inflammatory Bowel Diseases · 209
Postoperative recurrent luminal Crohnʼs Disease: A systematic review
2011 · Peter De Cruz, Michael A. Kamm, et al. · Inflammatory Bowel Diseases · 192
Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study
2014 · Peter De Cruz, Seungha Kang, et al. · Journal of Gastroenterology and Hepatology · 157
An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease
2016 · Matthew C. Choy, Kumar Visvanathan, et al. · Inflammatory Bowel Diseases · 141
Mucosal Healing in Crohnʼs Disease
2012 · Peter De Cruz, Michael A. Kamm, et al. · Inflammatory Bowel Diseases · 140
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis
2015 · P. De Cruz, M. A. Kamm, et al. · Alimentary Pharmacology & Therapeutics · 138
EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review
2016 · Belinda D. Jackson, Kathleen Gray, et al. · Journal of Crohn s and Colitis · 126
Comparative Law in a Changing World
2024 · Peter De Cruz · Routledge eBooks · 123
PDF
Visceral adiposity predicts post‐operative Crohn's disease recurrence
2017 · D. Q. Holt, G. T. Moore, et al. · Alimentary Pharmacology & Therapeutics · 116
PDF
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
2023 · Edouard Louis, Matthieu Resche-Rigon, et al. · ˜The œLancet. Gastroenterology & hepatology · 112
Microbial Factors Associated with Postoperative Crohn’s Disease Recurrence
2016 · Emily K. Wright, Michael A. Kamm, et al. · Journal of Crohn s and Colitis · 112
PDF
Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools
2016 · Danny Con, Peter De Cruz · JMIR mhealth and uhealth · 100
Review article: the practical management of acute severe ulcerative colitis
2016 · D. Seah, P. De Cruz · Alimentary Pharmacology & Therapeutics · 100
PDF
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
2019 · Matthew C Choy, Dean Seah, et al. · Inflammatory Bowel Diseases · 96
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011 · Peter De Cruz, Lani Prideaux, et al. · Inflammatory Bowel Diseases · 95
Impact of Ethnicity, Geography, and Disease on the Microbiota in Health and Inflammatory Bowel Disease
2013 · Lani Prideaux, Seungha Kang, et al. · Inflammatory Bowel Diseases · 90
Chromoendoscopy versus Narrow Band Imaging for Colonic Surveillance in Inflammatory Bowel Disease
2013 · Marios Efthymiou, Patrick B. Allen, et al. · Inflammatory Bowel Diseases · 87
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
2021 · Julien D Schulberg, Emily K Wright, et al. · ˜The œLancet. Gastroenterology & hepatology · 73
Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis
2016 · Zaid Shihab, Neville D. Yeomans, et al. · Journal of Crohn s and Colitis · 72
Works count: 326
Citation count: 6,593
H-index: 38
I10-index: 98
Year
Topic
Type